pmc logo image
Logo of envhperEHP WebsiteAbout EHPPublicationsNews By TopicAuthorsSubscribePressEmail AlertsSearch EHP

Formats:

Environ Health Perspect. 1998 March; 106(3): 115–125.
PMCID: PMC1533055
Research Article
Potential health effects of gasoline and its constituents: A review of current literature (1990-1997) on toxicological data.
L Caprino and G I Togna
Institute of Medical Pharmacology, University of Rome "La Sapienza," Rome, Italy.
Abstract
We reviewed toxicological studies, both experimental and epidemiological, that appeared in international literature in the period 1990-1997 and included both leaded and unleaded gasolines as well as their components and additives. The aim of this overview was to select, arrange, and present references of scientific papers published during the period under consideration and to summarize the data in order to give a comprehensive picture of the results of toxicological studies performed in laboratory animals (including carcinogenic, teratogenic, or embryotoxic activity), mutagenicity and genotoxic aspects in mammalian and bacterial systems, and epidemiological results obtained in humans in relation to gasoline exposure. This paper draws attention to the inherent difficulties in assessing with precision any potential adverse effects on health, that is, the risk of possible damage to man and his environment from gasoline. The difficulty of risk assessment still exists despite the fact that the studies examined are definitely more technically valid than those of earlier years. The uncertainty in overall risk determination from gasoline exposure also derives from the conflicting results of different studies, from the lack of a correct scientific approach in some studies, from the variable characteristics of the different gasoline mixtures, and from the difficulties of correctly handling potentially confounding variables related to lifestyle (e.g., cigarette smoking, drug use) or to preexisting pathological conditions. In this respect, this paper highlights the need for accurately assessing the conclusive explanations reported in scientific papers so as to avoid the spread of inaccurate or misleading information on gasoline toxicity in nonscientific papers and in mass-media messages.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Wixtrom RN, Brown SL. Individual and population exposures to gasoline. J Expo Anal Environ Epidemiol. 1992 Jan–Mar;2(1):23–78. [PubMed]
  • Akland GG. Exposure of the general population to gasoline. Environ Health Perspect. 1993 Dec;101 Suppl 6:27–32. [PubMed]
  • Partanen T, Heikkilä P, Hernberg S, Kauppinen T, Moneta G, Ojajärvi A. Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health. 1991 Aug;17(4):231–239. [PubMed]
  • Enterline PE. Review of new evidence regarding the relationship of gasoline exposure to kidney cancer and leukemia. Environ Health Perspect. 1993 Dec;101 Suppl 6:101–103. [PubMed]
  • Schnatter AR, Katz AM, Nicolich MJ, Thériault G. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect. 1993 Dec;101 Suppl 6:85–99. [PubMed]
  • Rushton L. A 39-year follow-up of the U.K. oil refinery and distribution center studies: results for kidney cancer and leukemia. Environ Health Perspect. 1993 Dec;101 Suppl 6:77–84. [PubMed]
  • Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Occupational risk factors for renal-cell carcinoma in Denmark. Scand J Work Environ Health. 1994 Jun;20(3):160–165. [PubMed]
  • Lynge E, Andersen A, Nilsson R, Barlow L, Pukkala E, Nordlinder R, Boffetta P, Grandjean P, Heikkilä P, Hörte LG, Jakobsson R, Lundberg I, Moen B, Partanen T, Riise T. Risk of cancer and exposure to gasoline vapors. Am J Epidemiol. 1997 Mar 1;145(5):449–458. [PubMed]
  • Infante PF. State of the science on the carcinogenicity of gasoline with particular reference to cohort mortality study results. Environ Health Perspect. 1993 Dec;101 Suppl 6:105–109. [PubMed]
  • Poole C, Dreyer NA, Satterfield MH, Levin L, Rothman KJ. Kidney cancer and hydrocarbon exposures among petroleum refinery workers. Environ Health Perspect. 1993 Dec;101 Suppl 6:53–62. [PubMed]
  • Wong O, Harris F, Smith TJ. Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect. 1993 Dec;101 Suppl 6:63–76. [PubMed]
  • McLaughlin JK. Renal cell cancer and exposure to gasoline: a review. Environ Health Perspect. 1993 Dec;101 Suppl 6:111–114. [PubMed]
  • Lindquist R, Nilsson B, Eklund G, Gahrton G. Acute leukemia in professional drivers exposed to gasoline and diesel. Eur J Haematol. 1991 Aug;47(2):98–103. [PubMed]
  • Jakobsson R, Ahlbom A, Bellander T, Lundberg I. Acute myeloid leukemia among petrol station attendants. Arch Environ Health. 1993 Jul–Aug;48(4):255–259. [PubMed]
  • Collingwood KW, Raabe GK, Wong O. An updated cohort mortality study of workers at a northeastern United States petroleum refinery. Int Arch Occup Environ Health. 1996;68(5):277–288. [PubMed]
  • Raza H, Qureshi MM, Montague W. Alteration of glutathione, glutathione S-transferase and lipid peroxidation in mouse skin and extracutaneous tissues after topical application of gasoline. Int J Biochem Cell Biol. 1995 Mar;27(3):271–277. [PubMed]
  • Burbacher TM. Neurotoxic effects of gasoline and gasoline constituents. Environ Health Perspect. 1993 Dec;101 Suppl 6:133–141. [PubMed]
  • Loury DJ, Smith-Oliver T, Butterworth BE. Assessment of unscheduled and replicative DNA synthesis in rat kidney cells exposed in vitro or in vivo to unleaded gasoline. Toxicol Appl Pharmacol. 1987 Jan;87(1):127–140. [PubMed]
  • Vyskocil A, Cizkova M. Nephrotoxic effects of unleaded petrol in female rats. J Appl Toxicol. 1996 Jan–Feb;16(1):55–56. [PubMed]
  • Raabe GK. Review of the carcinogenic potential of gasoline. Environ Health Perspect. 1993 Dec;101 Suppl 6:35–38. [PubMed]
  • Borghoff SJ, Youtsey NL, Swenberg JA. A comparison of European High Test gasoline and PS-6 unleaded gasoline in their abilities to induce alpha 2u-globulin nephropathy and renal cell proliferation. Toxicol Lett. 1992 Oct;63(1):21–33. [PubMed]
  • Borghoff SJ, Short BG, Swenberg JA. Biochemical mechanisms and pathobiology of alpha 2u-globulin nephropathy. Annu Rev Pharmacol Toxicol. 1990;30:349–367. [PubMed]
  • Rodgers IS, Baetcke KP. Interpretation of male rat renal tubule tumors. Environ Health Perspect. 1993 Dec;101 Suppl 6:45–52. [PubMed]
  • Mitsumori K, Elwell MR. Proliferative lesions in the male reproductive system of F344 rats and B6C3F1 mice: incidence and classification. Environ Health Perspect. 1988 Apr;77:11–21. [PubMed]
  • Lehman-McKeeman LD, Caudill D. Alpha 2u-globulin is the only member of the lipocalin protein superfamily that binds to hyaline droplet inducing agents. Toxicol Appl Pharmacol. 1992 Oct;116(2):170–176. [PubMed]
  • Swenberg JA. Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ Health Perspect. 1993 Dec;101 Suppl 6:39–44. [PubMed]
  • Standeven AM, Wolf DC, Goldsworthy TL. Interactive effects of unleaded gasoline and estrogen on liver tumor promotion in female B6C3F1 mice. Cancer Res. 1994 Mar 1;54(5):1198–1204. [PubMed]
  • Standeven AM, Blazer DG, 3rd, Goldsworthy TL. Investigation of antiestrogenic properties of unleaded gasoline in female mice. Toxicol Appl Pharmacol. 1994 Aug;127(2):233–240. [PubMed]
  • Tilbury L, Butterworth BE, Moss O, Goldsworthy TL. Hepatocyte cell proliferation in mice after inhalation exposure to unleaded gasoline vapor. J Toxicol Environ Health. 1993 Mar;38(3):293–307. [PubMed]
  • Standeven AM, Goldsworthy TL. Promotion of preneoplastic lesions and induction of CYP2B by unleaded gasoline vapor in female B6C3F1 mouse liver. Carcinogenesis. 1993 Oct;14(10):2137–2141. [PubMed]
  • Standeven AM, Goldsworthy TL. Identification of hepatic mitogenic and cytochrome P-450-inducing fractions of unleaded gasoline in B6C3F1 mice. J Toxicol Environ Health. 1994 Oct;43(2):213–224. [PubMed]
  • Seeber A, Kiesswetter E, Neidhart B, Blaszkewicz M. Neurobehavioral effects of a long-term exposure to tetraalkyllead. Neurotoxicol Teratol. 1990 Nov–Dec;12(6):653–655. [PubMed]
  • Booze RM, Mactutus CF. Developmental exposure to organic lead causes permanent hippocampal damage in Fischer-344 rats. Experientia. 1990 Mar 15;46(3):292–297. [PubMed]
  • Audesirk T, Shugarts D, Cabell-Kluch L, Wardle K. The effects of triethyl lead on the development of hippocampal neurons in culture. Cell Biol Toxicol. 1995 Feb;11(1):1–10. [PubMed]
  • Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11;322(2):83–88. [PubMed]
  • Goyer RA. Results of lead research: prenatal exposure and neurological consequences. Environ Health Perspect. 1996 Oct;104(10):1050–1054. [PubMed]
  • Kawada T, Tri-Tugaswati A, Yasuo K, Suzuki S. Relationships between mean lead levels in the atmosphere and in blood from data published since 1977. Asia Pac J Public Health. 1994;7(4):233–235. [PubMed]
  • Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994 Jul 27;272(4):284–291. [PubMed]
  • Wietlisbach V, Rickenbach M, Berode M, Guillemin M. Time trend and determinants of blood lead levels in a Swiss population over a transition period (1984-1993) from leaded to unleaded gasoline use. Environ Res. 1995 Feb;68(2):82–90. [PubMed]
  • Bono R, Pignata C, Scursatone E, Rovere R, Natale P, Gilli G. Updating about reductions of air and blood lead concentrations in Turin, Italy, following reductions in the lead content of gasoline. Environ Res. 1995 Jul;70(1):30–34. [PubMed]
  • Schuhmacher M, Bellés M, Rico A, Domingo JL, Corbella J. Impact of reduction of lead in gasoline on the blood and hair lead levels in the population of Tarragona Province, Spain, 1990-1995. Sci Total Environ. 1996 May 31;184(3):203–209. [PubMed]
  • Goyer RA. Lead toxicity: current concerns. Environ Health Perspect. 1993 Apr;100:177–187. [PubMed]
  • Silbergeld EK. Lead poisoning: the implications of current biomedical knowledge for public policy. Md Med J. 1996 Mar;45(3):209–217. [PubMed]
  • Reese E, Kimbrough RD. Acute toxicity of gasoline and some additives. Environ Health Perspect. 1993 Dec;101 Suppl 6:115–131. [PubMed]
  • Garner CD, Lee EW, Louis-Ferdinand RT. Müller cell involvement in methanol-induced retinal toxicity. Toxicol Appl Pharmacol. 1995 Jan;130(1):101–107. [PubMed]
  • Garner CD, Lee EW, Terzo TS, Louis-Ferdinand RT. Role of retinal metabolism in methanol-induced retinal toxicity. J Toxicol Environ Health. 1995 Jan;44(1):43–56. [PubMed]
  • Rogers JM, Mole ML, Chernoff N, Barbee BD, Turner CI, Logsdon TR, Kavlock RJ. The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses. Teratology. 1993 Mar;47(3):175–188. [PubMed]
  • Cummings AM. Evaluation of the effects of methanol during early pregnancy in the rat. Toxicology. 1993 May 24;79(3):205–214. [PubMed]
  • Andrews JE, Ebron-McCoy M, Logsdon TR, Mole LM, Kavlock RJ, Rogers JM. Developmental toxicity of methanol in whole embryo culture: a comparative study with mouse and rat embryos. Toxicology. 1993 Aug 27;81(3):205–215. [PubMed]
  • Abbott BD, Logsdon TR, Wilke TS. Effects of methanol on embryonic mouse palate in serum-free organ culture. Teratology. 1994 Feb;49(2):122–134. [PubMed]
  • Lee E, Brady AN, Brabec MJ, Fabel T. Effects of methanol vapors on testosterone production and testis morphology in rats. Toxicol Ind Health. 1991 Jul;7(4):261–275. [PubMed]
  • Poon R, Chu I, Bjarnason S, Vincent R, Potvin M, Miller RB, Valli VE. Short-term inhalation toxicity of methanol, gasoline, and methanol/gasoline in the rat. Toxicol Ind Health. 1995 May–Jun;11(3):343–361. [PubMed]
  • Stern S, Reuhl K, Soderholm S, Cox C, Sharma A, Balys M, Gelein R, Yin C, Weiss B. Perinatal methanol exposure in the rat. I. Blood methanol concentration and neural cell adhesion molecules. Fundam Appl Toxicol. 1996 Nov;34(1):36–46. [PubMed]
  • Costantini MG. Health effects of oxygenated fuels. Environ Health Perspect. 1993 Dec;101 Suppl 6:151–160. [PubMed]
  • Lee EW, Terzo TS, D'Arcy JB, Gross KB, Schreck RM. Lack of blood formate accumulation in humans following exposure to methanol vapor at the current permissible exposure limit of 200 ppm. Am Ind Hyg Assoc J. 1992 Feb;53(2):99–104. [PubMed]
  • d'Alessandro A, Osterloh JD, Chuwers P, Quinlan PJ, Kelly TJ, Becker CE. Formate in serum and urine after controlled methanol exposure at the threshold limit value. Environ Health Perspect. 1994 Feb;102(2):178–181. [PubMed]
  • Osterloh JD, D'Alessandro A, Chuwers P, Mogadeddi H, Kelly TJ. Serum concentrations of methanol after inhalation at 200 ppm. J Occup Environ Med. 1996 Jun;38(6):571–576. [PubMed]
  • Cook MR, Bergman FJ, Cohen HD, Gerkovich MM, Graham C, Harris RK, Siemann LG. Effects of methanol vapor on human neurobehavioral measures. Res Rep Health Eff Inst. 1991 Aug;(42):1–45. [PubMed]
  • von Burg R. Methyl tert-butyl ether. J Appl Toxicol. 1992 Feb;12(1):73–74. [PubMed]
  • Daughtrey WC, Gill MW, Pritts IM, Douglas JF, Kneiss JJ, Andrews LS. Neurotoxicological evaluation of methyl tertiary-butyl ether in rats. J Appl Toxicol. 1997 May;17 Suppl 1:S57–S64. [PubMed]
  • Savolainen H, Pfäffli P, Elovaara E. Biochemical effects of methyl tertiary-butyl ether in extended vapour exposure of rats. Arch Toxicol. 1985 Sep;57(4):285–288. [PubMed]
  • Bird MG, Burleigh-Flayer HD, Chun JS, Douglas JF, Kneiss JJ, Andrews LS. Oncogenicity studies of inhaled methyl tertiary-butyl ether (MTBE) in CD-1 mice and F-344 rats. J Appl Toxicol. 1997 May;17 Suppl 1:S45–S55. [PubMed]
  • Lington AW, Dodd DE, Ridlon SA, Douglas JF, Kneiss JJ, Andrews LS. Evaluation of 13-week inhalation toxicity study on methyl t-butyl ether (MTBE) in Fischer 344 rats. J Appl Toxicol. 1997 May;17 Suppl 1:S37–S44. [PubMed]
  • Miller MJ, Ferdinandi ES, Klan M, Andrews LS, Douglas JF, Kneiss JJ. Pharmacokinetics and disposition of methyl t-butyl ether in Fischer-344 rats. J Appl Toxicol. 1997 May;17 Suppl 1:S3–12. [PubMed]
  • Brady JF, Xiao F, Ning SM, Yang CS. Metabolism of methyl tertiary-butyl ether by rat hepatic microsomes. Arch Toxicol. 1990;64(2):157–160. [PubMed]
  • Hutcheon DE, Arnold JD, ten Hove W, Boyle J., 3rd Disposition, metabolism, and toxicity of methyl tertiary butyl ether, an oxygenate for reformulated gasoline. J Toxicol Environ Health. 1996 Apr 5;47(5):453–464. [PubMed]
  • Conaway CC, Schroeder RE, Snyder NK. Teratology evaluation of methyl tertiary butyl ether in rats and mice. J Toxicol Environ Health. 1985;16(6):797–809. [PubMed]
  • Bevan C, Tyl RW, Neeper-Bradley TL, Fisher LC, Panson RD, Douglas JF, Andrews LS. Developmental toxicity evaluation of methyl tertiary-butyl ether (MTBE) by inhalation in mice and rabbits. J Appl Toxicol. 1997 May;17 Suppl 1:S21–S29. [PubMed]
  • Biles RW, Schroeder RE, Holdsworth CE. Methyl tertiary butyl ether inhalation in rats: a single generation reproduction study. Toxicol Ind Health. 1987 Dec;3(4):519–534. [PubMed]
  • Bevan C, Neeper-Bradley TL, Tyl RW, Fisher LC, Panson RD, Kneiss JJ, Andrews LS. Two-generation reproductive toxicity study of methyl tertiary-butyl ether (MTBE) in rats. J Appl Toxicol. 1997 May;17 Suppl 1:S13–S19. [PubMed]
  • Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen. 1987;9 Suppl 9:1–109. [PubMed]
  • McGregor DB, Brown A, Cattanach P, Edwards I, McBride D, Caspary WJ. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals. Environ Mol Mutagen. 1988;11(1):91–118. [PubMed]
  • McKee RH, Vergnes JS, Galvin JB, Douglas JF, Kneiss JJ, Andrews LS. Assessment of the in vivo mutagenic potential of methyl tertiary-butyl ether. J Appl Toxicol. 1997 May;17 Suppl 1:S31–S36. [PubMed]
  • Moser GJ, Wong BA, Wolf DC, Moss WR, Goldsworthy TL. Comparative short-term effects of methyl tertiary butyl ether and unleaded gasoline vapor in female B6C3F1 mice. Fundam Appl Toxicol. 1996 Jun;31(2):173–183. [PubMed]
  • Mackerer CR, Angelosanto FA, Blackburn GR, Schreiner CA. Identification of formaldehyde as the metabolite responsible for the mutagenicity of methyl tertiary-butyl ether in the activated mouse lymphoma assay. Proc Soc Exp Biol Med. 1996 Sep;212(4):338–341. [PubMed]
  • Casanova M, Heck HA. Lack of evidence for the involvement of formaldehyde in the hepatocarcinogenicity of methyl tertiary-butyl ether in CD-1 mice. Chem Biol Interact. 1997 Jul 11;105(2):131–143. [PubMed]
  • Prescott-Mathews JS, Wolf DC, Wong BA, Borghoff SJ. Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats. Toxicol Appl Pharmacol. 1997 Apr;143(2):301–314. [PubMed]
  • Poet TS, Borghoff SJ. In vitro uptake of methyl tert-butyl ether in male rat kidney: use of a two-compartment model to describe protein interactions. Toxicol Appl Pharmacol. 1997 Aug;145(2):340–348. [PubMed]
  • Borghoff SJ, Murphy JE, Medinsky MA. Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats. Fundam Appl Toxicol. 1996 Apr;30(2):264–275. [PubMed]
  • Olson MJ, Johnson JT, Reidy CA. A comparison of male rat and human urinary proteins: implications for human resistance to hyaline droplet nephropathy. Toxicol Appl Pharmacol. 1990 Mar 1;102(3):524–536. [PubMed]
  • Turek FW, Desjardins C. Development of Leydig cell tumors and onset of changes in the reproductive and endocrine systems of aging F344 rats. J Natl Cancer Inst. 1979 Oct;63(4):969–975. [PubMed]
  • Belpoggi F, Soffritti M, Maltoni C. Methyl-tertiary-butyl ether (MTBE)--a gasoline additive--causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Health. 1995 Mar–Apr;11(2):119–149. [PubMed]
  • Mennear JH. MTBE: not carcinogenic. Environ Health Perspect. 1995 Nov;103(11):985–986. [PubMed]
  • Hartle R. Exposure to methyl tert-butyl ether and benzene among service station attendants and operators. Environ Health Perspect. 1993 Dec;101 Suppl 6:23–26. [PubMed]
  • White MC, Johnson CA, Ashley DL, Buchta TM, Pelletier DJ. Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health. 1995 May–Jun;50(3):183–189. [PubMed]
  • Neoptolemos JP, Hall C, O'Connor HJ, Murray WR, Carr-Locke DL. Methyl-tert-butyl-ether for treating bile duct stones: the British experience. Br J Surg. 1990 Jan;77(1):32–35. [PubMed]
  • Leuschner U, Hellstern A, Schmidt K, Fischer H, Güldütuna S, Hübner K, Leuschner M. Gallstone dissolution with methyl tert-butyl ether in 120 patients--efficacy and safety. Dig Dis Sci. 1991 Feb;36(2):193–199. [PubMed]
  • vanSonnenberg E, Zakko S, Hofmann AF, D'Agostino HB, Jinich H, Hoyt DB, Miyai K, Ramsby G, Moossa AR. Human gallbladder morphology after gallstone dissolution with methyl tert-butyl ether. Gastroenterology. 1991 Jun;100(6):1718–1723. [PubMed]
  • Johanson G, Nihlén A, Löf A. Toxicokinetics and acute effects of MTBE and ETBE in male volunteers. Toxicol Lett. 1995 Dec;82-83:713–718. [PubMed]
  • Hong JY, Yang CS, Lee M, Wang YY, Huang WQ, Tan Y, Patten CJ, Bondoc FY. Role of cytochromes P450 in the metabolism of methyl tert-butyl ether in human livers. Arch Toxicol. 1997;71(4):266–269. [PubMed]
  • Moolenaar RL, Hefflin BJ, Ashley DL, Middaugh JP, Etzel RA. Methyl tertiary butyl ether in human blood after exposure to oxygenated fuel in Fairbanks, Alaska. Arch Environ Health. 1994 Sep–Oct;49(5):402–409. [PubMed]
  • Gordian ME, Huelsman MD, Brecht ML, Fisher DG. Health effects of methyl tertiary butyl ether (MTBE) in gasoline in Alaska. Alaska Med. 1995 Jul–Sep;37(3):101-3–119. [PubMed]
  • Hakkola M, Honkasalo ML, Pulkkinen P. Neuropsychological symptoms among tanker drivers exposed to gasoline. Occup Med (Lond). 1996 Apr;46(2):125–130. [PubMed]
  • Lindamood C, 3rd, Farnell DR, Giles HD, Prejean JD, Collins JJ, Takahashi K, Maronpot RR. Subchronic toxicity studies of t-butyl alcohol in rats and mice. Fundam Appl Toxicol. 1992 Jul;19(1):91–100. [PubMed]
  • Takahashi K, Lindamood C, 3rd, Maronpot RR. Retrospective study of possible alpha-2 mu-globulin nephropathy and associated cell proliferation in male Fischer 344 rats dosed with t-butyl alcohol. Environ Health Perspect. 1993 Dec;101 Suppl 5:281–285. [PubMed]
  • Cirvello JD, Radovsky A, Heath JE, Farnell DR, Lindamood C., 3rd Toxicity and carcinogenicity of t-butyl alcohol in rats and mice following chronic exposure in drinking water. Toxicol Ind Health. 1995 Mar–Apr;11(2):151–165. [PubMed]
  • Brooks TM, Meyer AL, Hutson DH. The genetic toxicology of some hydrocarbon and oxygenated solvents. Mutagenesis. 1988 May;3(3):227–232. [PubMed]
  • White RD, Daughtrey WC, Wells MS. Health effects of inhaled tertiary amyl methyl ether and ethyl tertiary butyl ether. Toxicol Lett. 1995 Dec;82-83:719–724. [PubMed]
  • Daughtrey WC, Bird MG. Genotoxicity and twenty-eight-day subchronic toxicity studies on tertiary amyl methyl ether. J Appl Toxicol. 1995 Jul–Aug;15(4):313–319. [PubMed]
  • Alexeeff GV, Kilgore WW, Li MY. Ethylene dibromide: toxicology and risk assessment. Rev Environ Contam Toxicol. 1990;112:49–122. [PubMed]
  • Romert L, Magnusson J, Ramel C. The importance of glutathione and glutathione transferase for somatic mutations in Drosophila melanogaster induced in vivo by 1,2-dichloroethane. Carcinogenesis. 1990 Aug;11(8):1399–1402. [PubMed]
  • Ballering LA, Nivard MJ, Vogel EW. Characterization of the genotoxic action of three structurally related 1,2-dihaloalkanes in Drosophila melanogaster. Mutat Res. 1993 Feb;285(2):209–217. [PubMed]
  • Storer RD, Cartwright ME, Cook WO, Soper KA, Nichols WW. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice. Carcinogenesis. 1995 Feb;16(2):285–293. [PubMed]
  • Loranger S, Zayed J. Environmental and occupational exposure to manganese: a multimedia assessment. Int Arch Occup Environ Health. 1995;67(2):101–110. [PubMed]
  • Frumkin H, Solomon G. Manganese in the U.S. gasoline supply. Am J Ind Med. 1997 Jan;31(1):107–115. [PubMed]
  • Lynam DR, Pfeifer GD, Fort BF, Gelbcke AA. Environmental assessment of MMT fuel additive. Sci Total Environ. 1990 Apr;93:107–114. [PubMed]
  • Iregren A. Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol Teratol. 1990 Nov–Dec;12(6):673–675. [PubMed]
  • Zayed J, Ducic S, Campanella G, Panisset JC, André P, Masson H, Roy M. Facteurs environnementaux dans l'étiologie de la maladie de Parkinson. Can J Neurol Sci. 1990 Aug;17(3):286–291. [PubMed]
  • Calne DB. Neurotoxins and degeneration in the central nervous system. Neurotoxicology. 1991 Fall;12(3):335–339. [PubMed]
  • Hua MS, Huang CC. Chronic occupational exposure to manganese and neurobehavioral function. J Clin Exp Neuropsychol. 1991 Jul;13(4):495–507. [PubMed]
  • Wennberg A, Hagman M, Johansson L. Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure. Neurotoxicology. 1992 Spring;13(1):271–274. [PubMed]
  • Mergler D, Huel G, Bowler R, Iregren A, Bélanger S, Baldwin M, Tardif R, Smargiassi A, Martin L. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res. 1994 Feb;64(2):151–180. [PubMed]
  • Zayed J, Gérin M, Loranger S, Sierra P, Bégin D, Kennedy G. Occupational and environmental exposure of garage workers and taxi drivers to airborne manganese arising from the use of methylcyclopentadienyl manganese tricarbonyl in unleaded gasoline. Am Ind Hyg Assoc J. 1994 Jan;55(1):53–58. [PubMed]
  • Sierra P, Loranger S, Kennedy G, Zayed J. Occupational and environmental exposure of automobile mechanics and nonautomotive workers to airborne manganese arising from the combustion of methylcyclopentadienyl manganese tricarbonyl (MMT). Am Ind Hyg Assoc J. 1995 Jul;56(7):713–716. [PubMed]
  • Komura J, Sakamoto M. Chronic oral administration of methylcyclopentadienyl manganese tricarbonyl altered brain biogenic amines in the mouse: comparison with inorganic manganese. Toxicol Lett. 1994 Jul;73(1):65–73. [PubMed]
  • Savitz DA, Andrews KW. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind Med. 1997 Mar;31(3):287–295. [PubMed]
  • Ruijten MW, Hooisma J, Brons JT, Habets CE, Emmen HH, Muijser H. Neurobehavioral effects of long-term exposure to xylene and mixed organic solvents in shipyard spray painters. Neurotoxicology. 1994 Fall;15(3):613–620. [PubMed]
  • Rothman N, Li GL, Dosemeci M, Bechtold WE, Marti GE, Wang YZ, Linet M, Xi LQ, Lu W, Smith MT, Titenko-Holland N, Zhang LP, Blot W, Yin SN, Hayes RB. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med. 1996 Mar;29(3):236–246. [PubMed]
  • Hsieh GC, Parker RD, Sharma RP, Hughes BJ. Subclinical effects of groundwater contaminants. III. Effects of repeated oral exposure to combinations of benzene and toluene on immunologic responses in mice. Arch Toxicol. 1990;64(4):320–328. [PubMed]
  • Shankar U, Kumar A, Rao GS, Dwivedi PP, Pandya KP, Ray PK. Modulation of benzene induced toxicity by protein A. Biochem Pharmacol. 1993 Aug 3;46(3):517–524. [PubMed]
  • Goldstein BD, Warren J. HEI's mobile air toxics project. Environ Health Perspect. 1993 Aug;101(3):256–258. [PubMed]
  • Lagorio S, Tagesson C, Forastiere F, Iavarone I, Axelson O, Carere A. Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occup Environ Med. 1994 Nov;51(11):739–743. [PubMed]
  • Snyder R, Kalf GF. A perspective on benzene leukemogenesis. Crit Rev Toxicol. 1994;24(3):177–209. [PubMed]
  • Orzechowski A, Schwarz LR, Schwegler U, Bock KW, Snyder R, Schrenk D. Benzene metabolism in rodent hepatocytes: role of sulphate conjugation. Xenobiotica. 1995 Nov;25(10):1093–1102. [PubMed]
  • Schlosser PM, Bond JA, Medinsky MA. Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis. 1993 Dec;14(12):2477–2486. [PubMed]
  • Subrahmanyam VV, Ross D, Eastmond DA, Smith MT. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic Biol Med. 1991;11(5):495–515. [PubMed]
  • Yardley-Jones A, Anderson D, Parke DV. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br J Ind Med. 1991 Jul;48(7):437–444. [PubMed]
  • Medinsky MA, Kenyon EM, Seaton MJ, Schlosser PM. Mechanistic considerations in benzene physiological model development. Environ Health Perspect. 1996 Dec;104 Suppl 6:1399–1404. [PubMed]
  • Medinsky MA, Schlosser PM, Bond JA. Critical issues in benzene toxicity and metabolism: the effect of interactions with other organic chemicals on risk assessment. Environ Health Perspect. 1994 Nov;102 Suppl 9:119–124. [PubMed]
  • Travis CC, Fox MT, Simmons WM, Lyon BF. Co-exposure to gasoline vapor decreases benzene metabolism in Fischer-344 rats. Toxicol Lett. 1992 Sep;62(2-3):231–240. [PubMed]
  • Paxman D, Rappaport SM. Analysis of OSHA's short-term-exposure limit for benzene. Regul Toxicol Pharmacol. 1990 Jun;11(3):275–287. [PubMed]
  • Weisel C, Yu R, Roy A, Georgopoulos P. Biomarkers of environmental benzene exposure. Environ Health Perspect. 1996 Dec;104 Suppl 6:1141–1146. [PubMed]
  • Raabe GK, Wong O. Leukemia mortality by cell type in petroleum workers with potential exposure to benzene. Environ Health Perspect. 1996 Dec;104 Suppl 6:1381–1392. [PubMed]
  • Lagorio S, Forastiere F, Iavarone I, Rapiti E, Vanacore N, Perucci CA, Carere A. Mortality of filling station attendants. Scand J Work Environ Health. 1994 Oct;20(5):331–338. [PubMed]
  • Bezabeh S, Engel A, Morris CB, Lamm SH. Does benzene cause multiple myeloma? An analysis of the published case-control literature. Environ Health Perspect. 1996 Dec;104(Suppl 6):1393–1398. [PubMed]
  • Wong O, Raabe GK. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. Regul Toxicol Pharmacol. 1997 Oct;26(2):188–199. [PubMed]
  • Nilsson RI, Nordlinder RG, Tagesson C, Walles S, Järvholm BG. Genotoxic effects in workers exposed to low levels of benzene from gasoline. Am J Ind Med. 1996 Sep;30(3):317–324. [PubMed]
  • Netterstrøm B, Suadicani P. Self-assessed job satisfaction and ischaemic heart disease mortality: a 10-year follow-up of urban bus drivers. Int J Epidemiol. 1993 Feb;22(1):51–56. [PubMed]
  • Popp W, Rauscher D, Müller G, Angerer J, Norpoth K. Concentrations of benzene in blood and S-phenylmercapturic and t,t-muconic acid in urine in car mechanics. Int Arch Occup Environ Health. 1994;66(1):1–6. [PubMed]
  • Hakkola M, Saarinen L. Exposure of tanker drivers to gasoline and some of its components. Ann Occup Hyg. 1996 Feb;40(1):1–10. [PubMed]
  • Moolenaar RL, Hefflin BJ, Ashley DL, Middaugh JP, Etzel RA. Blood benzene concentrations in workers exposed to oxygenated fuel in Fairbanks, Alaska. Int Arch Occup Environ Health. 1997;69(2):139–143. [PubMed]
  • Paustenbach DJ, Bass RD, Price P. Benzene toxicity and risk assessment, 1972-1992: implications for future regulation. Environ Health Perspect. 1993 Dec;101 Suppl 6:177–200. [PubMed]
  • Saito K, Wada H. Behavioral approaches to toluene intoxication. Environ Res. 1993 Jul;62(1):53–62. [PubMed]
  • Tegeris JS, Balster RL. A comparison of the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fundam Appl Toxicol. 1994 Feb;22(2):240–250. [PubMed]
  • Cintra A, Andbjer B, Finnman UB, Hagman M, Agnati LF, Höglund G, Fuxe K. Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat. Neurosci Lett. 1996 Oct 11;217(1):61–65. [PubMed]
  • Gralewicz S, Wiaderna D, Tomas T. Development of spontaneous, age-related nonconvulsive seizure electrocortical activity and radial-maze learning after exposure to m-xylene in rats. Int J Occup Med Environ Health. 1995;8(4):347–360. [PubMed]
  • Pryor G, Rebert C, Kassay K, Kuiper H, Gordon R. The hearing loss associated with exposure to toluene is not caused by a metabolite. Brain Res Bull. 1991 Jul;27(1):109–113. [PubMed]
  • Crofton KM, Lassiter TL, Rebert CS. Solvent-induced ototoxicity in rats: an atypical selective mid-frequency hearing deficit. Hear Res. 1994 Oct;80(1):25–30. [PubMed]
  • Liu Y, Fechter LD. Toluene disrupts outer hair cell morphometry and intracellular calcium homeostasis in cochlear cells of guinea pigs. Toxicol Appl Pharmacol. 1997 Feb;142(2):270–277. [PubMed]
  • Poon R, Chu I, Bjarnason S, Potvin M, Vincent R, Miller RB, Valli VE. Inhalation toxicity study of methanol, toluene, and methanol/toluene mixtures in rats: effects of 28-day exposure. Toxicol Ind Health. 1994 May–Jun;10(3):231–245. [PubMed]
  • Ono A, Sekita K, Ohno K, Hirose A, Ogawa Y, Saito M, Naito K, Kaneko T, Furuya T, Matsumoto K, et al. Reproductive and developmental toxicity studies of toluene. I. Teratogenicity study of inhalation exposure in pregnant rats. J Toxicol Sci. 1995 May;20(2):109–134. [PubMed]
  • Ono A, Sekita K, Ogawa Y, Hirose A, Suzuki S, Saito M, Naito K, Kaneko T, Furuya T, Kawashima K, Yasuhara K, Matsumoto K, Tanaka S, Inoue T, Kurokawa Y. Reproductive and developmental toxicity studies of toluene. II. Effects of inhalation exposure on fertility in rats. J Environ Pathol Toxicol Oncol. 1996;15(1):9–20. [PubMed]
  • Hass U, Lund SP, Simonsen L, Fries AS. Effects of prenatal exposure to xylene on postnatal development and behavior in rats. Neurotoxicol Teratol. 1995 May–Jun;17(3):341–349. [PubMed]
  • Wilkins-Haug L. Teratogen update: toluene. Teratology. 1997 Feb;55(2):145–151. [PubMed]
  • Uchida Y, Nakatsuka H, Ukai H, Watanabe T, Liu YT, Huang MY, Wang YL, Zhu FZ, Yin H, Ikeda M. Symptoms and signs in workers exposed predominantly to xylenes. Int Arch Occup Environ Health. 1993;64(8):597–605. [PubMed]
  • Ukai H, Takada S, Inui S, Imai Y, Kawai T, Shimbo S, Ikeda M. Occupational exposure to solvent mixtures: effects on health and metabolism. Occup Environ Med. 1994 Aug;51(8):523–529. [PubMed]
  • Smargiassi A, Mutti A, Bergamaschi E, Bélanger S, Truchon G, Mergler D. Pilot study of peripheral markers of catecholaminergic systems among workers occupationally exposed to toluene. Neurotoxicology. 1996 Fall–Winter;17(3-4):769–775. [PubMed]
  • Foo SC, Ngim CH, Salleh I, Jeyaratnam J, Boey KW. Neurobehavioral effects in occupational chemical exposure. Environ Res. 1993 Feb;60(2):267–273. [PubMed]
  • Wood RW, Cox C. A repeated measures approach to the detection of the acute behavioral effects of toluene at low concentrations. Fundam Appl Toxicol. 1995 May;25(2):293–301. [PubMed]
  • Greenberg MM. The central nervous system and exposure to toluene: a risk characterization. Environ Res. 1997 Jan;72(1):1–7. [PubMed]
  • Lawryk NJ, Lioy PJ, Weisel CP. Exposure to volatile organic compounds in the passenger compartment of automobiles during periods of normal and malfunctioning operation. J Expo Anal Environ Epidemiol. 1995 Oct–Dec;5(4):511–531. [PubMed]
  • Tardif R, Plaa GL, Brodeur J. Influence of various mixtures of inhaled toluene and xylene on the biological monitoring of exposure to these solvents in rats. Can J Physiol Pharmacol. 1992 Mar;70(3):385–393. [PubMed]
  • Mehlman MA. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry: Part I. Carcinogenicity of motor fuels: gasoline. Toxicol Ind Health. 1991 Sep–Nov;7(5-6):143–152. [PubMed]
  • Mehlman MA, Legator MS. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry--Part II: Carcinogenicity, mutagenicity, and developmental toxicity of 1,3-butadiene. Toxicol Ind Health. 1991 May;7(3):207–220. [PubMed]
  • Mehlman MA. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry. VIII. Health effects of motor fuels: carcinogenicity of gasoline--scientific update. Environ Res. 1992 Oct;59(1):238–249. [PubMed]
  • Mehlman MA. Dangerous and cancer-causing properties of products and chemicals in the oil-refining and petrochemical industry--Part XXII: Health hazards from exposure to gasoline containing methyl tertiary butyl ether: study of New Jersey residents. Toxicol Ind Health. 1996 Sep–Oct;12(5):613–627. [PubMed]
  • Lotti M. IARC ranking of carcinogenicity evidence: how is the message delivered and perceived? Regul Toxicol Pharmacol. 1994 Apr;19(2):236–241. [PubMed]
  • Caprino L. Evaluation of drug safety by toxicological test procedures as provided by regulatory laws: an overview. Pharmacol Res. 1990 May–Jun;22(3):253–262. [PubMed]